Is it safe to co‑administer amoxicillin‑clavulanate and azithromycin in a patient with an estimated glomerular filtration rate of 59 mL/min?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-Administration of Amoxicillin-Clavulanate and Azithromycin at GFR 59 mL/min

Yes, both amoxicillin-clavulanate and azithromycin can be safely co-administered in a patient with a GFR of 59 mL/min, but amoxicillin-clavulanate requires dose adjustment while azithromycin does not.

Renal Function Classification

  • A GFR of 59 mL/min places this patient in Stage 3a chronic kidney disease (CKD), defined as moderately reduced kidney function (GFR 45-59 mL/min/1.73 m²). 1
  • This level of renal impairment requires monitoring of kidney function every 3-6 months and careful attention to drug dosing. 1

Amoxicillin-Clavulanate Dosing at GFR 59 mL/min

Reduce the standard dose by extending the dosing interval from every 8 hours to every 12 hours, or reduce each dose by approximately 50%. 2

  • For mild-to-moderate infections, use 500 mg/125 mg every 12 hours instead of the standard every 8-hour regimen to account for decreased amoxicillin clearance while maintaining adequate clavulanic acid exposure. 2
  • Amoxicillin clearance decreases more significantly than clavulanic acid clearance as renal function declines, with total body clearance of amoxicillin being more affected than clavulanic acid in patients with GFR 35-75 mL/min. 3
  • The ratio of amoxicillin to clavulanic acid exposure increases from approximately 4.9 at GFR 75 mL/min to 5.3 at GFR 35-75 mL/min, indicating differential accumulation. 3
  • Do not exceed 6 grams of amoxicillin per day to minimize the risk of neurotoxicity from drug accumulation. 2

Azithromycin Dosing at GFR 59 mL/min

No dose adjustment is required for azithromycin at this level of renal function.

  • Azithromycin is primarily eliminated through biliary excretion rather than renal clearance, making it safe to use at standard doses even with moderate renal impairment. 1
  • Standard dosing of 500 mg on day 1 followed by 250 mg daily for 4 days, or 500 mg daily for 3 days, can be used without modification. 1

Safety Monitoring Requirements

Monitor renal function within 2-3 days if clinical deterioration occurs or if intercurrent illness develops. 4

  • Check serum creatinine and electrolytes if the patient develops diarrhea, dehydration, or receives other nephrotoxic medications. 1, 4
  • Avoid combining with NSAIDs or other nephrotoxic agents that could further impair amoxicillin clearance and precipitate acute kidney injury. 2
  • Temporarily suspend or further reduce the amoxicillin-clavulanate dose if acute illness, dehydration, or contrast administration occurs. 2
  • Increase monitoring frequency when GFR is below 60 mL/min, as recommended for all renally cleared medications. 1

Drug Interaction Considerations

There are no significant pharmacokinetic interactions between amoxicillin-clavulanate and azithromycin that would preclude their co-administration.

  • Both antibiotics can be used simultaneously without dose adjustment for the azithromycin component. 1
  • The combination provides broad-spectrum coverage and is commonly used in clinical practice for community-acquired pneumonia and other mixed infections. 1

Key Clinical Pitfalls to Avoid

  • Do not use standard every-8-hour dosing of amoxicillin-clavulanate at GFR 59 mL/min, as this will lead to amoxicillin accumulation and increased risk of adverse effects including crystalluria and neurotoxicity. 2, 3
  • Do not assume serum creatinine alone reflects true renal function in elderly patients with reduced muscle mass, as creatinine-based equations may underestimate the degree of renal impairment by one CKD stage in over 30% of cases. 1
  • Watch for signs of drug accumulation including confusion, seizures, or other neurological manifestations if therapy extends beyond 7-10 days. 2
  • Be vigilant for crystalluria if very high doses are used or if renal function deteriorates further toward GFR 15 mL/min, though this risk is minimal at GFR 59 mL/min. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Augmentin Dosing Adjustments in Patients with a GFR of Approximately 45 mL/min/1.73 m²

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Antibiotic Selection for Patients with Normal Renal Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.